Fig. 4From: BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathwayKaplan–Meier curves showing the association of aberrant expression of BKCa, ERK1/2 and p-ERK1/2 with disease-free survival (DFS) and overall survival (OS) in 185 patients with type I endometrial cancer. High expression of p-ERK1/2 (c, f) was significantly associated with shorter DFS (p = 2.81E− 4) and OS (p = 4.18E− 4) in endometrial adenocarcinoma patients; in contrast, both BKCa and ERK1/2 expressions were not significantly associated with DFS or OS (a-e)Back to article page